Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.
about
Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cellsThe receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexesVascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cellsHuman monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitorVEGF-initiated angiogenesis and the uPA/uPAR systemPlasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular formsProcessing of complex between urokinase and its type-2 inhibitor on the cell surfaceThe plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis.Plasminogen activators in synovial fluid and plasma from patients with arthritisThe urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators.New insights into the role of Plg-RKT in macrophage recruitment.Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors.A plasminogen activator is induced during goldfish optic nerve regenerationProtease-nexin I as an androgen-dependent secretory product of the murine seminal vesicle.The urokinase receptor is required for human monocyte chemotaxis in vitro.Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombinUrokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.cDNA cloning of human plasminogen activator-inhibitor from endothelial cellsSecretory products of macrophages.Regulation and role of urokinase plasminogen activator in vascular remodelling.Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpressionAAV-mediated overexpression of neuroserpin in the hippocampus decreases PSD-95 expression but does not affect hippocampal-dependent learning and memory.Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.Inhibition of endothelial wound repair by dominant negative connexin inhibitors.Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytesBinding of Lys-plasminogen to monocytes/macrophages.Transcriptional and posttranscriptional control of c-fos gene expression in human monocytesKeratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in miceRegulation of fibrin deposition by malignant mesotheliomaSites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney.Regional heterogeneity of glycoconjugate distribution in the glomerulus revealed by lectin-gold cytochemistry and SDS-PAGEA cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell typeEnhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.Urokinase-type plasminogen activator is induced in migrating capillary endothelial cellsMouse ovarian granulosa cells produce urokinase-type plasminogen activator, whereas the corresponding rat cells produce tissue-type plasminogen activator.
P2860
Q24612910-527C9438-9331-4CCD-AFDC-992B50FE64ADQ24678932-CDAC30AD-17D4-4B48-9552-C00A59BF5F38Q24679724-2A5E10F1-EE51-4B68-9421-017DA3B7A987Q24682654-EBED0B9D-9C7C-4652-B69A-16EBF2541A87Q27025897-250BA161-F1E1-418A-A846-59F812A24FFBQ28285553-7AE669BE-EB96-4708-9223-D969B6ABE6D7Q29306421-34747254-AA8C-40B9-91A1-CEBC1640B6D8Q33504867-85D53EDA-2D11-45BD-A8B9-707D0821D825Q33564961-81C7EF7D-0B7A-4422-96EC-820FF125848BQ33649574-3235230A-C435-4064-ACF7-18186AFDFC3EQ33680725-6E6232B7-0531-4498-826C-185ED8ECAD57Q33768031-3142FDC8-AC41-46C0-BF41-01BD62152E4FQ33848822-B4F918E7-B46B-46C4-A078-4E6ECDA5E927Q33895912-1EF622E4-64FF-403A-B45C-3B8F125FADB6Q33924144-2FF54D92-B862-4ECB-9D39-235A13447B94Q34050038-5886A698-95D9-4723-8375-54ADFC676B8CQ34137611-5D5F1F1A-0E8D-4A3F-9138-D0221B4C00B8Q34256090-6AC0AF62-6565-466C-B778-A9A6C32A0C21Q34489359-998804D1-37E6-4BD0-84A6-29806116C543Q34551601-66D80F93-1287-486D-A756-C42990FA6115Q34557411-09F19607-F88E-47A2-A620-4A1317695D46Q34736190-A4F69ACA-B546-42EB-90D8-8B4F549343E3Q35098346-098CD321-B0A7-4220-8249-BB76BA70FA77Q35114530-F99636F1-6B6B-4A80-A466-ACDAFFC142E5Q35208646-57B4934E-CA94-4929-AB1D-A9BE9F812583Q35581431-CEED69BA-FE88-4C70-B300-C40259B67ADCQ35588164-DF0FCB9C-3B4C-431F-94B1-E1104F3B34E1Q35594485-5A6DCBBE-FB41-4D72-9B86-F597315BA782Q35619290-6D003DC8-A7D0-4037-B417-F6E99174FB18Q35786944-DF469906-4443-4E89-BFEF-A69164BFE8F6Q35795542-5B3CDEF2-7A7E-4ACF-8B23-14F9D4078749Q35819933-4D9C5CDD-12F5-47FB-AB01-644082066F11Q35836591-26879283-8A7D-4CE3-ACB1-374077D547EFQ36211634-E8E55E44-E2A3-4B1E-8E68-C61F6372E1B1Q36216416-74F9AC97-5BF6-42C8-980E-30F0DE4DDA88Q36216545-76EA85E6-5A8E-4D4F-A5F2-7F4C8D183152Q36216679-C90742B0-0624-40BB-B0CF-B7166741E92FQ36217085-C7B75484-35FB-48F8-846F-C2C356AA4DEDQ36217171-7286F051-E428-470B-9B3A-85061CE6799AQ36217388-2299E115-EE2D-4B67-98B1-2030600EF5DF
P2860
Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Concomitant secretion of prour ...... d human monocytes-macrophages.
@en
Concomitant secretion of prour ...... d human monocytes-macrophages.
@nl
type
label
Concomitant secretion of prour ...... d human monocytes-macrophages.
@en
Concomitant secretion of prour ...... d human monocytes-macrophages.
@nl
prefLabel
Concomitant secretion of prour ...... d human monocytes-macrophages.
@en
Concomitant secretion of prour ...... d human monocytes-macrophages.
@nl
P2093
P2860
P356
P1476
Concomitant secretion of prour ...... d human monocytes-macrophages.
@en
P2093
P2860
P304
P356
10.1084/JEM.159.6.1653
P407
P577
1984-06-01T00:00:00Z